CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 32 enrolled
Drug / intervention
Combined Oral Contraceptive Pill +1 moredrug
Likely dose
Combined Oral Contraceptive Pill 150 mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01968135
NCT01968135Phase 2Completed
CompareCT.gov

Does Concomitant Use of Combined Oral Hormonal Steroids Stop Bleeding in Women Using Etonogestrel Implants (Implanon/Nexplanon®)?: A Randomized Controlled Study

University of Colorado, Denver·interventional·Posted Oct 23, 2013·Updated May 5, 2016

In Brief

A Phase 2 clinical trial evaluating Combined Oral Contraceptive Pill and Placebo Sugar Pill for Uterine Hemorrhage and Contraception. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The specific aims are to determine if more women using Etonogestrel (ENG) contraceptive implants who report a bleeding-spotting episode of at least seven days will stop bleeding within 3 days of beginning a 14-day course of combined oral hormonal steroids, as compared to women receiving 14 days of placebo.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUterine Hemorrhage, Contraception
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 23, 2013
Enrollment StartOct 1, 2013
Primary CompletionNov 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 12.7 years ago

Interventions

Combined Oral Contraceptive Pilldrug

150 mcg levonorgestrel and 30 mcg ethinyl estradiol combined oral contraceptive pill

Placebo Sugar Pilldrug

Placebo Sugar Pill